Banking, payments, and financial services for psychedelic businesses

Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

For founders and operators of licensed psilocybin service centers in Oregon and natural medicine healing centers in Colorado who want to understand the banking and payment access challenges their businesses face and what options currently exist.

The short answer

Banking access is one of the most significant operational challenges for licensed psychedelic businesses. Most federally insured financial institutions — national banks, most regional banks, and credit unions with federal charters — will not provide standard business banking services to psilocybin businesses because doing so implicates federal anti-money-laundering statutes applicable to proceeds from federally illegal activity. Psilocybin’s Schedule I status under federal law is the root of the problem, and it does not change because Oregon or Colorado authorized the business under state law. The practical result is that many service centers and healing centers operate with limited banking access — relying on state-chartered credit unions, cannabis-friendly financial institutions, or cash-heavy operations — while the federal banking access problem remains unresolved at the legislative level. Understanding the available options is essential operational planning for any psychedelic business.

Why federal law creates the banking problem

The Bank Secrecy Act (31 U.S.C. § 5311 et seq.) and related anti-money-laundering statutes require federally regulated financial institutions to file Suspicious Activity Reports (SARs) for transactions that may involve proceeds of illegal activity. Because psilocybin is a Schedule I controlled substance under the Controlled Substances Act, revenue from a psilocybin business — even a fully licensed Oregon or Colorado operation — constitutes proceeds from the sale of a federally illegal substance from the federal banking regulator’s perspective. A bank that knowingly processes transactions for a psilocybin business risks BSA violations, money laundering exposure under 18 U.S.C. § 1956 and § 1957, and loss of its federal charter or deposit insurance.

The federal government has not extended to psilocybin businesses the limited FinCEN guidance it provided to cannabis businesses in 2014 — guidance that told financial institutions how to serve cannabis businesses while managing their SAR obligations. Without equivalent guidance for psilocybin businesses, federally regulated institutions face unguided compliance risk that most are unwilling to accept.

What this means operationally

A psilocybin service center that cannot access standard business banking faces several concrete operational problems. It cannot accept credit or debit card payments — payment processors are typically bank-sponsored and decline to process payments for federally illegal businesses. It cannot use standard payroll services. It may not be able to obtain a standard business checking account. Vendor payments may need to be made in cash or by money order. Payroll may need to be paid in cash. Insurance premiums may need to be paid in ways that bypass standard electronic payment systems.

Cash-heavy operations create their own problems: theft risk, difficulty meeting payroll tax obligations accurately, limited ability to document expenses for tax purposes, and the inability to build a standard banking relationship that would support future financing or investor due diligence.

What banking options currently exist

Despite the federal access problem, banking options for psychedelic businesses are not zero — they are limited and require active research rather than standard bank outreach.

State-chartered credit unions and community development financial institutions (CDFIs) that are not federally insured or that have made a policy decision to serve state-licensed cannabis and psychedelic businesses are the most accessible options. Some Oregon state-chartered credit unions that have served cannabis businesses have extended those policies to psilocybin businesses. These institutions typically require the business to demonstrate its state licensure, undergo compliance due diligence similar to what cannabis businesses face, and in some cases pay higher fees than standard commercial accounts.

Cannabis-friendly financial institutions — banks and credit unions that developed compliance programs for the cannabis industry after 2014 — are a second category. Many of these institutions are in states with legal cannabis programs and have invested in compliance infrastructure for Schedule I-adjacent businesses. Some serve Oregon and Colorado psychedelic businesses as a natural extension of that infrastructure.

The number of financial institutions serving psilocybin businesses in Oregon has grown since the program launched in 2023, though it remains small relative to standard commercial banking availability. Operators should ask OPS-licensed facilitators and service center networks for referrals to institutions that are currently accepting psychedelic business clients — this information is shared informally in the Oregon psilocybin community and is more current than any published directory.

Payment processing

Credit and debit card processing for psilocybin businesses faces the same structural problem as banking — card networks (Visa, Mastercard, American Express, Discover) prohibit processing of payments for federally illegal businesses under their merchant agreements. A payment processor that accepts a psilocybin merchant violates its card network agreement.

Some service centers use workarounds that have been common in the cannabis industry: ACH transfers directly between client and business bank accounts (where both parties have accounts at institutions willing to process the transfer), cash payments, or payment apps that are not card-network-based. The viability of each workaround depends on the specific financial institutions involved and changes as those institutions update their policies.

Some payment technology companies specifically serve the cannabis and psychedelic industries and have built compliance infrastructure designed to operate within the current banking constraints. These services are more expensive than standard payment processing — fees in the 3–5% range are common, compared to 1.5–2.5% for standard card processing — but provide a functional alternative to cash-only operations.

Accepting payment in cryptocurrency is technically possible but creates its own complications: volatility risk, tax treatment complexity, and the practical reality that most clients are not prepared to pay in cryptocurrency for wellness services.

Client payment and the cash-pay model

Oregon’s psilocybin services are entirely out-of-pocket — no health insurance covers psilocybin sessions, and the federal Schedule I status forecloses Medicare and Medicaid reimbursement. Every client pays out of pocket, typically in the $1,200–$3,000 range per session. This makes the payment access problem particularly acute: the business model is inherently cash-intensive, and every client payment is a transaction the standard financial system will not process.

Service centers that solve the banking and payment problem — whether through state-chartered credit union relationships or compliant payment technology — have a meaningful operational advantage over those operating primarily in cash.

Merchant accounts and e-commerce

A service center that wants to accept online booking payments or deposits faces the same card network prohibition. Some scheduling platforms that serve the cannabis and psychedelic industries have built payment infrastructure that works around card network restrictions. A service center evaluating scheduling software should confirm whether the platform includes a payment component and, if so, whether that component is legally compliant and operationally functional for psilocybin businesses in their jurisdiction.

Federal legislative developments

The SAFE Banking Act — legislation that would provide a federal safe harbor for financial institutions serving state-licensed cannabis businesses — has passed the House of Representatives multiple times but has not been enacted into law as of early 2026. The SAFE Banking Act does not cover psilocybin businesses; it is limited to cannabis. No equivalent federal banking legislation has been introduced for psilocybin businesses as of early 2026.

If psilocybin is rescheduled federally following an FDA approval — a plausible scenario given COMPASS Pathways’ NDA timeline — the banking problem may resolve naturally, as a Schedule II or III substance with accepted medical use would not carry the same federally-illegal-proceeds concern. But rescheduling is not guaranteed, and the timeline is uncertain. Operators should plan for the current banking environment rather than assume legislative relief is imminent.

Insurance and other financial services

Business insurance for psychedelic businesses faces similar access constraints to banking, though the specialty insurance market for state-licensed psychedelic operations has developed more quickly than the banking market. See Insurance for psychedelic businesses: what is available and what is not for the insurance-specific analysis.

Merchant cash advances, business loans, and other forms of debt financing are difficult to access through standard lenders for the same reasons standard banking is difficult. Private lenders and impact investors who specifically target the cannabis and psychedelic industry are the realistic financing options for most service centers and healing centers at this stage of the market.

When public information may be enough

The Bank Secrecy Act provisions relevant to psilocybin businesses are at 31 U.S.C. § 5311 et seq. FinCEN’s 2014 cannabis guidance — which provides context for the psilocybin banking problem even though it does not cover psilocybin — is publicly available at fincen.gov. Oregon’s state-chartered credit union directory is available through the Oregon Division of Financial Regulation at dfr.oregon.gov.

When you should speak with a lawyer

A service center operator who is structuring their banking and payment approach should consult with both a lawyer familiar with the federal banking and money transmission framework and an accountant familiar with cash-intensive businesses before finalizing their operational approach. An operator who has been told by a financial institution that it is closing their account based on their psilocybin business activity should consult a lawyer before responding. A service center evaluating a payment processing arrangement that involves a third party holding client funds should have the arrangement reviewed for money transmission licensing compliance.

You might also want to read

This article is for general informational purposes only and does not constitute legal advice. Banking regulations, payment processing policies, and financial services availability for psychedelic businesses change frequently. For advice specific to your business’s financial structure, consult a licensed attorney and a qualified financial professional with experience in regulated cannabis or psychedelic businesses.